Drug pipeline
Full profile accessExplore the programs pursuing this target and their development progress.
- Drug candidates
- Developers
- Development stage
Target intelligence / Profile preview
Adenosine receptors are a family of G protein-coupled receptors (GPCRs) that mediate the physiological and pharmacological effects of adenosine. There are four well-characterized subtypes: A1, A2A, A2B, and A3. They are involved in a wide range of biological processes, including neuromodulation, cardiac function, immune response, and inflammation. Developing selective drugs targeting specific adenosine receptor subtypes remains challenging due to the widespread distribution and sometimes opposing functions of these receptors.
Agonists or antagonists of adenosine receptors, modulating intracellular cAMP levels and other downstream signaling pathways depending on the specific receptor subtype and tissue context.
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Explore the programs pursuing this target and their development progress.
Follow the clinical studies evaluating therapies directed at this target.
Compare approaches across drug candidates, modalities, and indications.
Investigate the research and source evidence behind target biology and development.
Explore patent activity around therapies and technologies addressing this target.
Connect target biology, drug development, and emerging evidence in your research.
See how Gosset can support your research on Adenosine Receptors (ADORs).